Published March 25, 2024 | Version v4
Other Open

Supplementary files to Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity

  • 1. Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany
  • 2. Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
  • 3. Jimma University Clinical Trial Unit, Jimma University Institute of Health, Jimma, Ethiopia
  • 4. Max von Pettenkofer Institute, Munich, Germany; Gene Center, Virology, National Reference Center for Retroviruses, LMU Munich, Munich, Germany
  • 5. Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Munich, Germany
  • 6. Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany; Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Germany
  • 7. Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany
  • 8. Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany; Immunology, Infection and Pandemic Research IIP, Fraunhofer ITMP, Munich, Germany
  • 9. Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany; Immunology, Infection and Pandemic Research IIP, Fraunhofer ITMP, Munich, Germany; German Center for Infection Research, partner site Munich, Munich, Germany; Center for International Health, LMU Munich, Munich, Germany
  • 10. Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany; Institute of Computational Biology, Helmholtz Zentrum München—German Research Center for Environmental Health, Neuherberg, Germany; Center for Mathematics, Technische Universität München, Garching, Germany
  • 11. Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany; German Center for Infection Research, partner site Munich, Munich, Germany
  • 12. Max von Pettenkofer Institute, Munich, Germany; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany; Immunology, Infection and Pandemic Research IIP, Fraunhofer ITMP, Munich, Germany; German Center for Infection Research, partner site Munich, Munich, Germany

Description

Supplementary files containing the "multivariant" model version 20230522_175758 and the "antibody-level" model version 20230327_182130_compr. Also includes code for creation of model, parameter estimation problem and figures. 

Files

20230327_182130_compr.zip

Files (4.9 MB)

Name Size Download all
md5:f946bcb10bcc6a01d60b4ddf14352ca9
12.1 kB Preview Download
md5:ca43ec5f0ad0db98c66d82c9930c3a83
50.7 kB Preview Download
md5:90ce05cea7595810f4c890705d02be2e
77.6 kB Preview Download
md5:9730cfcbe821406f60fcfa0ebb7855f5
4.8 MB Preview Download